Electrochemical and optical methods for detection of cystatin C as a biomarker of kidney disease

被引:0
|
作者
Zhang, Jiakui [1 ]
Ren, Baiping [2 ]
Liu, Jingxuan [3 ]
Li, Hongwu [4 ]
机构
[1] China Med Univ, Affiliated Hosp 4, Dept Surg Oncol, Shenyang 110032, Liaoning, Peoples R China
[2] Shangjing Hosp, Dept Urol, Chifeng 024000, Inner Mongolia, Peoples R China
[3] China Med Univ, Affiliated Hosp 4, Dept Urol, Shenyang 110032, Liaoning, Peoples R China
[4] China Med Univ, Dept Gen Surg, Affiliated Hosp 4, Shenyang 110032, Liaoning, Peoples R China
关键词
Chronic kidney disease; Cystatin C; Biomarker; Electrochemical biosensor; Optical biosensor; GLOMERULAR-FILTRATION-RATE; GAMMA-TRACE; SERUM; MARKER; IMMUNOASSAY; ASSAY; IMMUNOSENSOR; BIOSENSOR; SENSOR; ELISA;
D O I
10.1016/j.cbi.2024.111355
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The kidneys have vital functions in the body, including maintaining homeostasis and blood pressure, controlling water-electrolyte balance, and eliminating metabolic wastes. Early identification of renal dysfunction disease and selection of effective treatment methods reduce mortality in patients. Nowadays, Common indicators of kidney function lack the necessary specificity and sensitivity, but recent studies have reported that cystatin C (CysC) may be an ideal marker for glomerular filtration. CysC, known as a cysteine protease inhibitor, is synthesized by nucleated cells and is easily filtered due to its positive charge and low molecular weight. Also, the synthesis and secretion of CysC is a stable process that is not affected by dietary factors, enhanced protein catabolism, and renal conditions. Various studies have reported that measuring the level of CysC in the body's biological fluids is necessary for the treatment and diagnosis of a wide range of diseases, especially chronic kidney disease (CKD). Despite evidence that positive correlation between the high risk and/or progression of CKD and CysC, it's applied in clinical practice is still rare. Biosensors have been widely developed and researched as an effective method for the pharmaceutical, environmental, and medical fields. Biosensors are designed to create an effective electronic signal commensurate with the concentration of a particular biochemical.Recently, many studies have used biosensor techniques to detect CysC in kidneys and other diseases. In this study, we attempt to examine studies that have used different biosensor techniques for the detect CysC.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Insufficient performance of serum cystatin C as a biomarker for acute kidney injury of postrenal etiology
    Julia Hasslacher
    Georg F. Lehner
    Michael Joannidis
    Intensive Care Medicine, 2012, 38 : 170 - 171
  • [42] Emerging biomarker for predicting acute kidney injury after cardiac surgery: cystatin C
    Saydam, Onur
    Turkmen, Ercan
    Portakal, Oytun
    Arici, Mustafa
    Dogan, Riza
    Demircin, Metin
    Pasaoglu, Ilhan
    Yilmaz, Mustafa
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2018, 48 (06) : 1096 - 1103
  • [43] Recent Advances in Electrochemical and Optical Biosensors for Cancer Biomarker Detection
    Son, Min Hyeong
    Park, Seok Won
    Sagong, Hee Yeon
    Jung, Yun Kyung
    BIOCHIP JOURNAL, 2023, 17 (01) : 44 - 67
  • [44] Recent Advances in Electrochemical and Optical Biosensors for Cancer Biomarker Detection
    Min Hyeong Son
    Seok Won Park
    Hee Yeon Sagong
    Yun Kyung Jung
    BioChip Journal, 2023, 17 : 44 - 67
  • [45] Cystatin C levels are highly predictive of outcome in chronic kidney disease
    Nature Clinical Practice Nephrology, 2007, 3 (10): : 524 - 524
  • [46] The association of plasma cystatin C proteoforms with diabetic chronic kidney disease
    Hussein N. Yassine
    Olgica Trenchevska
    Zhiwei Dong
    Yara Bashawri
    Juraj Koska
    Peter D. Reaven
    Randall W. Nelson
    Dobrin Nedelkov
    Proteome Science, 14
  • [47] Chronic kidney disease staging in the very old: the role of cystatin C
    Lopez, Begona Padrones
    Menendez, Lucia Ovies
    Roldan, Libia Cristina Perez
    Martinez, Jusmer Kennyon Serrano
    Herrera, Laura Manuela Robayo
    Munoz, Javier Montero
    Fernandez, Alejandra Fernandez
    Rodriguez, Ivan Veloso
    Gil-Albert, Carmen Garcia
    Garcia, Minerva Rodriguez
    Alonso, Carlos Gomez
    Alvarez, Eva Maria Lopez
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [48] Serum Cystatin C Concentrations in Cats with Hyperthyroidism and Chronic Kidney Disease
    Williams, T. L.
    Dillon, H.
    Elliott, J.
    Syme, H. M.
    Archer, J.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2016, 30 (04): : 1083 - 1089
  • [49] The association of plasma cystatin C proteoforms with diabetic chronic kidney disease
    Yassine, Hussein N.
    Trenchevska, Olgica
    Dong, Zhiwei
    Bashawri, Yara
    Koska, Juraj
    Reaven, Peter D.
    Nelson, Randall W.
    Nedelkov, Dobrin
    PROTEOME SCIENCE, 2016, 14
  • [50] Serum Cystatin C Trajectory Is a Marker Associated With Diabetic Kidney Disease
    Wang, Nana
    Lu, Zhenyu
    Zhang, Wei
    Bai, Yu
    Pei, Dongmei
    Li, Ling
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13